Dr. Pietro Genovese, PhD, is an Assistant Professor of Pediatrics at Harvard Medical School and Principal Investigator at the Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dr. Genovese was previously a Project Leader at the San Raffaele Telethon Institute for Gene Therapy, having completed his post-doctoral fellowship in the laboratory of Molecular and Cell Biology of Gene Transfer with Professor Luigi Naldini in Italy. In the last 15 years, his research has focused on developing genome editing tools that improve safety and efficacy of adoptive immunotherapy and promoting safer applications of human hematopoietic stem cell (HSC) gene therapy.
His current efforts are aimed to move these advanced genetic engineering strategies towards an effective therapeutic treatment for inherited and acquired hematologic diseases. Dr. Genovese is the author of several high-profile publications, coinventor of more than 10 patents on gene editing technology, and the recipient of several awards including the Young Investigator Award from the ESGCT society in 2016.